These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8297402)

  • 1. Amyloid, amyloid-inducers, cytokines and heavy metals in scrapie and other human and animal subacute spongiform encephalopathies: some hypotheses.
    Agrimi U; Di Guardo G
    Med Hypotheses; 1993 Feb; 40(2):113-6. PubMed ID: 8297402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructure and pathology of prion protein amyloid accumulation and cellular damage in extraneural tissues of scrapie-infected transgenic mice expressing anchorless prion protein.
    Race B; Jeffrey M; McGovern G; Dorward D; Chesebro B
    Prion; 2017 Jul; 11(4):234-248. PubMed ID: 28759310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated human tau associates with mouse prion protein amyloid in scrapie-infected mice but does not increase progression of clinical disease.
    Race B; Phillips K; Kraus A; Chesebro B
    Prion; 2016 Jul; 10(4):319-30. PubMed ID: 27463540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
    Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
    Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scrapie-associated PrP accumulation and agent replication: effects of sulphated glycosaminoglycan analogues.
    Caughey B
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):399-404. PubMed ID: 7913757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunolocalization of scrapie amyloid in non-congophilic, non-birefringent deposits in golden Syrian hamsters with experimental transmissible mink encephalopathy.
    Guiroy DC; Marsh RF; Yanagihara R; Gajdusek DC
    Neurosci Lett; 1993 May; 155(1):112-5. PubMed ID: 8103204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to scrapie and perspectives on current scrapie research.
    Kimberlin RH
    Prog Clin Biol Res; 1989; 317():559-66. PubMed ID: 2574870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling the culprit in Alzheimer's disease (AD): bacterial toxic proteins - Will they be significant for the aetio-pathogenesis of AD and the transmissible spongiform encephalopathies?
    Schmitt HP
    Med Hypotheses; 2007; 69(3):596-609. PubMed ID: 17337124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox metals and oxidative abnormalities in human prion diseases.
    Petersen RB; Siedlak SL; Lee HG; Kim YS; Nunomura A; Tagliavini F; Ghetti B; Cras P; Moreira PI; Castellani RJ; Guentchev M; Budka H; Ironside JW; Gambetti P; Smith MA; Perry G
    Acta Neuropathol; 2005 Sep; 110(3):232-8. PubMed ID: 16096758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kinetic model for amyloid formation in the prion diseases: importance of seeding.
    Come JH; Fraser PE; Lansbury PT
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5959-63. PubMed ID: 8327467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
    Weissmann C
    FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Western blot mapping of disease-specific amyloid in various animal species and humans with transmissible spongiform encephalopathies using a high-yield purification method.
    Beekes M; Baldauf E; Cassens S; Diringer H; Keyes P; Scott AC; Wells GA; Brown P; Gibbs CJ; Gajdusek DC
    J Gen Virol; 1995 Oct; 76 ( Pt 10)():2567-76. PubMed ID: 7595360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overactivation of calcineurin induced by amyloid-beta and prion proteins.
    Agostinho P; Lopes JP; Velez Z; Oliveira CR
    Neurochem Int; 2008 May; 52(6):1226-33. PubMed ID: 18295934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of prion protein in spongiform encephalopathies and normal brain tissue.
    Piccardo P; Safar J; Ceroni M; Gajdusek DC; Gibbs CJ
    Neurology; 1990 Mar; 40(3 Pt 1):518-22. PubMed ID: 1690364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
    Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
    Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis.
    Priola SA; Caughey B
    Mol Neurobiol; 1994; 8(2-3):113-20. PubMed ID: 7999307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the frequency and distribution of vascular and parenchymal amyloid with polyclonal and N-terminal-specific PrP antibodies in scrapie-affected sheep and mice.
    Jeffrey M; Goodsir CM; Holliman A; Higgins RJ; Bruce ME; McBride PA; Fraser JR
    Vet Rec; 1998 May; 142(20):534-7. PubMed ID: 9637378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
    DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.